Skip to main content
Michael Park, MD, Ophthalmology, Teaneck, NJ, The Mount Sinai Hospital

MichaelM.ParkMD

Ophthalmology Teaneck, NJ

Retinal Disease

Vitreoretinal surgeon

Dr. Park is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Park's full profile

Already have an account?

Education & Training

  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiFellowship, Surgical Retina and Vitreous, 2021 - 2023
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterChief Residency, Ophthalmology, 2020 - 2021
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterResidency, Ophthalmology, 2018 - 2021
  • Hackensack University Medical Center/Englewood Hospital and Medical Center
    Hackensack University Medical Center/Englewood Hospital and Medical CenterInternship, Internal Medicine, 2017 - 2018
  • Tufts University School of Medicine
    Tufts University School of MedicineClass of 2017

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2023 - 2025
  • NY State Medical License
    NY State Medical License 2021 - 2024
  • CT State Medical License
    CT State Medical License 2018 - 2021
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Resident Teaching Award New York Eye and Ear Infirmary of Mount Sinai, 2023
  • Marvin Sears Award for Clinical Excellence Yale Eye Center, 2021
  • Susan Hall Forster Resident as Teacher Award Yale Eye Center, 2021
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Ocular Neisseria gonorrhea in a patient on immune checkpoint inhibitors  
    Sopeyin A, Park MM, Pointdujour-Lim R, Oman Journal of Ophthalmology., 9/14/2021

Abstracts/Posters

  • Square Root of Baseline Lesion Number is a Correction Factor for the Geographic Atrophy Growth Rate.
    Shen LL, Sun M, Ahluwalia A, Young B, Park MM, Toth C, Lad EM, Del Priore LV., Investigative Ophthalmology & Visual Science, 6/10/2020

Other Languages

  • Spanish, Korean

Hospital Affiliations